Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, ...

The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen ...

Puma Biotech (PBYI) delivered earnings and revenue surprises of +90.00% and +6.27%, respectively, for the quarter ended June ...

“You could have the cure for cancer, but if you can’t execute, it doesn’t matter.” ...

A transatlantic partnership gives biotech startups lower-cost access to lab equipment while reducing waste and Scope 3 ...

The company is on the verge of becoming a commercial-stage biotech, with two promising therapies in phase 3 trials.

A new generation of female entrepreneurs are leading a monumental shift in the beauty industry, replacing fossil fuel-derived ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive ...

In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...

Fortress Biotech transformed its balance sheet by selling a Priority Review Voucher for $205 million, netting $159 million.